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While ZnPor retains significant dark 
toxicity, photoactivation of ZnPor 
has complete virucidal activity.
-Obligately lytic bacteriophage 
PEV2 has significant bactericidal 
activity against Pseudomonas 
aeruginosa.
-There is a significant synergistic 
effect against P. aeruginosa biofilms 
when ZnPor is used in combination 
with PEV2 that can be seen 
quantitatively & qualitatively 
(confocal laser scanning 
microscopy)
-The significance of the combination 
therapy is increased when 
photoactivated
The rise of multidrug resistant (MDR) 
pathogens is one of the greatest medical 
concerns of the century. The use of 
antibiotics in these infections is almost 
entirely useless, with almost 80% of 
human infections involving biofilms which 
can be up to 1000-fold more resistant to 
antibiotics than planktonic cells, leaving 
patients at a higher risk of mortality. One 
primary pathogen of concern is 
Pseudomonas aeruginosa, a deadly 
biofilm-producing bacterium that causes 
severe human infections and exhibits a 
high mortality rate for 
immunocompromised individuals. This 
resistance has sparked an urgent need to 
look for alternative antimicrobial therapies, 
such as phage therapy. In phage therapy, 
lytic bacteriophages eliminate bacteria that 
cause infection, even those caused my 
MDR pathogens. Our lab has examined a 
successful combinational therapy that 
treats biofilms of P. aeruginosa using a 
lytic bacteriophage (PEV2) and our novel 
patented porphyrin (ZnPor).
Figure 1: Biofilms grown on polyethylene coupons and subjected to a 
combination treatment consisting of ZnPor (25µM) and phage PEV2 (MOI 
10:1) then treated for 20 mins with and without light
Figure 2: Phage quantifications after combination treatment residing on 
polyethylene coupons 
Figure 3: Planktonic PAO1 is completely killed 
by ZnPor (25µM) by 2 hours
Figure 5: Planktonic PAO1 is completely lysed 
by PEV2 (MOI 10:1)  at 4 hours
Figure 4: Phage subjected to ZnPor (25µM) in the presence 
of light (300W) showed complete and immediate virucidal 
activity. 
